Why the study?
The study was conducted to assess the possibilities of quantitative MRI in the diagnosis and monitoring of rhabdomyolysis of various etiologies.
Does quantitative MRI with T1, T2, and T2* relaxometry improve the diagnosis and monitoring of rhabdomyolysis in patients with clinical manifestations?
Population
80 patients with clinical manifestations of rhabdomyolysis
Comparison
Standard T1, T2, and STIR protocols vs quantitative pulse sequences for T1, T2, and T2* relaxation times
Design
Diagnostic observational study
Authors
Loading...
Supports T2 relaxometry as a noninvasive biomarker in rhabdomyolysis; leaves open prospective validation before clinical adoption.
Does quantitative MRI with T1, T2, and T2* relaxometry improve the diagnosis and monitoring of rhabdomyolysis in patients with clinical manifestations?
Quantitative MRI with T2 relaxometry provides high sensitivity and specificity for diagnosing rhabdomyolysis and can serve as a non-invasive biomarker for monitoring muscle tissue recovery.
Emelyantsev et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: